Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-059287
Filing Date
2025-06-30
Accepted
2025-06-30 09:00:12
Documents
2
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0247262-6k_regencell.htm 6-K 10005
2 REGENCELL BIOSCIENCE HOLDINGS LIMITED ANNOUNCES FIRST HALF 2025 MANAGEMENT FINAN ea024726201ex99-1_regencell.htm EX-99.1 68292
  Complete submission text file 0001213900-25-059287.txt   79428
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 251088892
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)